KOL Health

Pharmaceutical Industry Services

KOL Health Services

KOLs are an invaluable resource to pharmaceutical companies when researching, launching, and marketing new drugs into the the market. They bring valuable insights into disease states and the associated patient treatments.

KOL Health can provide a faster alternative to the traditionally slow and expensive process of assembling a medical review panel, planning and reviewing publications and reviewing or consulting on continuing medical education programs. Our advisors are available to offer their input at the discovery or clinical trial phase of new pharmaceutical products.

Rapidly convene a panel of experts

We have the ability to rapidly convene a small panel of experts in a specific therapeutic area. Our advisors are experts in the areas of cardiology, pain management, diabetes, and geriatric diseases.

Our medical and clinical experts are spread across Canada, which means travel time and costs are often not a factor, helping reduce both the time and costs associated with medical review panels.

Pharmaceutical Marketing Consulting

KOL Health provides a readily accessible pool of expert medical advisors in various therapeutic fields, many with cross-therapeutic experience. Our medical experts are an invaluable resource at all stages of a marketing campaign. More information ...

Pharmaceutical Advertising & Marketing Consulting

KOL Health advisors are frequently called upon to work with pharmaceutical marketing and advertising agencies and their medical copywriters for their input on advertising content. Our advisors understand the PAAB advertising guidelines , as well as the importance of product launch timelines. More information ...

Medical Continuing Education Programs

Our Medical experts are available to assist in the design and building of your Continuing medical education programs. More Information ...

Pharmaceutical Advisory Service

Our advisors, a diverse group of Canadian primary care physicians, specialists, pharmacists, physiotherapists, and audiologists, are readily available to offer valuable input and objective feedback, either in person or online. More information ...

To discuss the value our advisors can add to your next pharmaceutical research or marketing campaign, please contact us today.

More Articles
  • Weight Loss Success Tips


  • “SICK DAY” MEDICATION ADVICE:


  • New article: European Society for Hypertension

    I attended the meeting of European Society for Hypertension in Oslo Norway, during June 18 - 21, 2010.

    I note this year there were no new blockbuster drugs released at the time of the meeting nor were there any major clinical trials released for review.

    There was lots of practical information related to obesity, salt intake and exercise in the management and treatment of hypertension as well as several excellent lectures on different aspects of hypertension and newer combinations of medications such as Coversyl with amlodipine (Coveram) and Nifedipine and Telmisartan.

  • Microalbuminuria Screening

    A Comparative Evaluation of Various Methods for Microalbuminuria Screening

    Dr. Bakris and I met at a recent ASN meeting and discussed a tool that can be used in primary care screening for nephropathy. Subsequent to that, Dr. Bakris wrote the paper below with the screening device utilized in the trial.


    - Dr Murray Awde




    A Comparative Evaluation of Various Methods for Microalbuminuria Screening



    Pantelis A. Sarafidis a, c Jessica Riehle a Zvezdana Bogojevic a Emad Basta a Atul Chugh b George L. Bakris b



    a Hypertension/Clinical Research Center, Department of Preventive Medicine, Rush University Medical Center, and b Hypertensive Diseases Unit, Section of Endocrinology, Diabetes and Metabolism, University of Chicago-Pritzker School of Medicine, Chicago, Ill. , USA; c Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA University Hospital, Aristotle University of Thesaloniki, Thessaloniki , Greece



    Key Words - Urinary albumin excretion, Hypertension, Diabetes, Kidney disease



    Abstract



    Background/Aims: Microalbuminuria is a marker of abnormal vascular response and a predictor of cardiovascular morbidity and mortality. We evaluated a new quantitative office-based method to assess urinary albumin excretion (UAE) and compared it to other established methods.


More Articles Questions Our Contributors

Site developer: In House Logic ©2009 - 2012 KOL Health Inc. Privacy Policy Mobile: m.kolhealth.com